Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bryant

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitorsDaniel D Holsworth, Mehran Jalaie, Thomas Belliotti, et al.
Bioorganic & Medicinal Chemistry|June 19, 2007
Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitorsNoel A Powell, Fred L Ciske, Cuiman Cai, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2006
Ketopiperazine-based renin inhibitors: optimization of the "C" ringDaniel D Holsworth, Cuiman Cai, Xue-Min Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2003
American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant settingEric P Winer, Clifford Hudis, Harold J Burstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2004
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004Eric P Winer, Clifford Hudis, Harold J Burstein, et al.
The New England Journal of Medicine|October 21, 2005
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancerEdward H Romond, Edith A Perez, John Bryant, et al.
Plant Biotechnology Journal|September 12, 2015
Global agricultural intensification during climate change: a role for genomicsMichael Abberton, Jacqueline Batley, Alison Bentley, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Does neoadjuvant therapy reduce pancreatic fistula after pancreatoduodenectomy and distal pancreatectomy?-a systematic review and meta-analysisSandro Hügli, Victor Lopez-Lopez, Sarvar Abdurakhmonov, et al.
Frontiers in Plant Science|September 1, 2015
Application of genomics-assisted breeding for generation of climate resilient crops: progress and prospectsChittaranjan Kole, Mehanathan Muthamilarasan, Robert Henry, et al.
International Journal of Radiation Oncology, Biology, Physics|February 22, 2020
Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to TodayPaul W Sperduto, Shane Mesko, Jing Li, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitorsDaniel D Holsworth, Mehran Jalaie, Thomas Belliotti, et al.
Bioorganic & Medicinal Chemistry|June 19, 2007
Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitorsNoel A Powell, Fred L Ciske, Cuiman Cai, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2006
Ketopiperazine-based renin inhibitors: optimization of the "C" ringDaniel D Holsworth, Cuiman Cai, Xue-Min Cheng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2003
American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant settingEric P Winer, Clifford Hudis, Harold J Burstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2004
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004Eric P Winer, Clifford Hudis, Harold J Burstein, et al.
The New England Journal of Medicine|October 21, 2005
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancerEdward H Romond, Edith A Perez, John Bryant, et al.
Plant Biotechnology Journal|September 12, 2015
Global agricultural intensification during climate change: a role for genomicsMichael Abberton, Jacqueline Batley, Alison Bentley, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Does neoadjuvant therapy reduce pancreatic fistula after pancreatoduodenectomy and distal pancreatectomy?-a systematic review and meta-analysisSandro Hügli, Victor Lopez-Lopez, Sarvar Abdurakhmonov, et al.
Frontiers in Plant Science|September 1, 2015
Application of genomics-assisted breeding for generation of climate resilient crops: progress and prospectsChittaranjan Kole, Mehanathan Muthamilarasan, Robert Henry, et al.
International Journal of Radiation Oncology, Biology, Physics|February 22, 2020
Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to TodayPaul W Sperduto, Shane Mesko, Jing Li, et al.
Pageof 8